Human Immunodeficiency Virus Infection in End-Stage Renal Disease Patients

Seminars in Dialysis

Volumn 16, Issue 3, 2003, Pages 233-244

  Rao, T K Sreepada ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Box 52 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADEFOVIR DIPIVOXIL; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FOTOVASE; HYDROXYUREA; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TRANSFUSION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; DRUG ABUSE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG URINE LEVEL; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PROGNOSIS; REVIEW; SEROLOGY; SEXUAL BEHAVIOR; SURVIVAL; TREATMENT OUTCOME; VIRUS TRANSMISSION; CHRONIC KIDNEY FAILURE; COMORBIDITY; DISEASE TRANSMISSION; IMMUNOLOGY; PARAMEDICAL PERSONNEL; RENAL REPLACEMENT THERAPY;

AIDS-ASSOCIATED NEPHROPATHY; ALLIED HEALTH PERSONNEL; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMORBIDITY; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PROGNOSIS; RENAL DIALYSIS;

EID: 0141672045     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.16047.x     Document Type: Review

References (103)

1. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310:669-673, 1984
2. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062-1073, 1987
3. Rao TKS, Friedman EA: AIDS (HIV) associated nephropathy: does it exist?, an in-depth review. Am J Nephrol 9:441-453, 1989
4. Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V: The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 12:131-137, 1988
5. Appel GB, Nicolaides MN: Human immunodeficiency virus acquired immunodeficiency syndrome nephropathy in the inner city. N Y State J Med 91:207-210, 1991
6. Frasseto L, Schoenfeld PY, Humphreys MH: Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital. Am J Kidney Dis 18:655-659, 1991
7. Geerlings W, Fassbinder W, Brunner FP: HIV infection in patients on renal replacement therapy, 1985-1988 data from the EDTA registry. Kidney Int 37:184, 1990
8. Tokras JI, Alter MJ, Miller E, Moyer LA, Favero MS: National surveillance of dialysis-associated diseases in the United States, 1994. ASAIO J 43:108-119, 1997
9. Winston J, Klotman PE: Are we missing an epidemic of HIV associated nephropathy? J Am Soc Nephrol 7:1-7, 1996
10. Murthy BVR, Pereira BJG: A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients. Semin Nephrol 17:346-363, 1997
11. Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomerantz A: Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr 119:710-716, 1991
12. Strauss J, Abitbol C, Zilleruello G, Scott G, Parades A, Malaga S, Montane B, Mitchell C, Parks W, Pardo V: Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 321:625-630, 1989
13. Winston JA, Klotman ME, Klotman PE: HIV associated nephropathy is a late, not early manifestation of HIV-1 infection. Kidney Int 55:1036-1040, 1999
14. Schoenfeld PY, Rodriguez R, Mendelson M: Patients with HIV infection and end-stage renal disease. Adv Ren Replace Ther 3:287-292, 1996
15. Neff MS, Hodgson ME, Rasmussen G, Waring S: HIV Infected Dialysis Patients in New York State. 1996 Annual Report. New York: ESRD Network of New York, 1996
16. U.S. Renal Data System: USRDS Annual Reports. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997-2001
17. Marcus R, Favero MS, Banerjee S, Solomon SL, Bell DM, Jarvis WR, Martone WJ, and the cooperative dialysis study group. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. Am J Med 90:614-619, 1991
18. Chirgwin K, Rao TKS, Landesman SH: HIV infection in a high prevalence hemodialysis unit. AIDS 3:731-735, 1989
19. Reiser I, Shapiro W, Porush J: The incidence and epidemiology of human immunodeficiency virus infection in 320 patients treated in an inner city hemodialysis center. Am J Kidney Dis 16:26-31, 1990
20. Human immunodeficiency virus infection in hemodialysis patients. Baltimore-Boston Collaborative Study Group. Arch Intern Med 148:617-619, 1988
21. Perez G, Ortiz-Interian C, Lee H, De Medina M, Cerney M, Allain JP, Schiff E, Parks E, Parks W, Bourgoignie JJ: Human immunodeficiency virus and human T-cell leukemia virus in patients undergoing maintenance hemodialysis in Miami. Am J Kidney Dis 14:39-43, 1989
22. Peterman TA, Lang GR, Mikos NJ, Solomon SJ, Schable CA, Feorino PM, Britz JA, Allen JR: HTLV-III/LAV infection in hemodialysis patients. JAMA 255:2324-2326, 1986
23. Kerman RH, Flechner SM, Van Buren CT, Lorber MI, Dawson G, Falk L, Gutierrez R, Hollinger JB, Kahan BD: Investigation of HTLV-3 serology in a renal transplant population. Transplantation 43:244-248, 1987
24. Heyka RJ, Magnusson M, Nakamoto S, Popowniak KL, Paganini EP: HIV screening in a hemodialysis population [abstract 34]. ASAIO annual meeting, Reno, Nevada, May 1988
25. Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP: Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 44:373-378, 1993
26. Rao TKS: Acquired immunodeficiency syndrome (AIDS), human immunodeficiency virus (HIV), and dialysis. In: Andreucci VE, Fine LG (eds). International Yearbook of Nephrology 1991. Boston: Kluwer Academic, 1990:199-218
27. Falcao HA, Rebelo M: Anti-HIV antibodies in a population of 132 patients in hemodialysis [abstract]. X International Congress of Nephrology. London, August 1987
28. Morikawa K, Kuroda M, Tofuku Y, Uehara H, Koshikawa S: Prevalence of ATLV and HIV among hemodialysis patients in Japan. Nephron 50:77-78, 1988
29. Hassan NF, el Ghoran NM, Abdel Rahim MS, Sharkawy E, El Sayed NM, Emara K, Soltant Y, Sanad M, Hibbs RG, Arthur RR: HIV infection in renal dialysis patients in Egypt. AIDS 8:853, 1994
30. Poignet JL, Desassis JF, Chanton N, Zinns B, Naret C, Kolko A, Patte R, Sobel A: Prevalence of HIV infection in dialysis patients. A French cooperative study. J Am Soc Nephrol 8:208A, 1997
31. Tokras JI, Miller ER, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 1997. Semin Dial 13:75-85, 2000
32. Rao TKS, Manis T, Friedman EA: Dismal prognosis despite maintenance hemodialysis in AIDS nephropathy and chronic uremia. Trans ASAIO 31:160-163, 1985
33. Ortiz C, Meneses R, Jaffe JA, Fernandez JA, Perez G, Bourgoignie JJ: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34:248-253, 1988
34. Ribot S, Dean D, Goldblat M, Saavedra M: Prognosis of HIV positive dialysis patients. Kidney Int 37:315, 1990
35. Feinfeld DA, Kaplan R, Dressler R, Lynn I: Survival of human immunodeficiency virus-infected patients on maintenance dialysis. Clin Nephrol 32:221-224, 1989
36. Rao TKS: Maintenance dialysis in patients with human immunodeficiency virus infection. Semin Dial 1:203-208, 1988
37. Lorch JA, Pollak VE: Outcomes in AIDS patients treated by dialysis. J Am Soc Nephrol 7:1455, 1996
38. Shrivastava D, Delano BG, Lundin P, Rao TKS, Markell M, Friedman EA: Factors affecting survival of HIV+ patients undergoing maintenance hemodialysis. J Am Soc Nephrol 3:320, 1992
39. Ifudu O, Mayers JD, Matthew JJ, Macey LJ, Brezsnyak W, Reydel C, McClendon E, Surgue T, Rao TKS, Friedman EA: Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? Am J Kidney Dis 29:549-552, 1997
40. Barth RH: Long survival of chronically dialyzed patients with HIV disease. J Am Soc Nephrol 7:1439, 1996
41. Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO: Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 44:191-198, 1993
42. Perinbasekar S, Brod-Miller C, Pal S, Mattana J: Predictor of survival in HIV-infected patients on hemodialysis. Am J Nephrol 16:280-286, 1996
43. Ahuja TS, Grady J, Khan S: Changing trends in the survival of dialysis patients with human immunodeficiency virus in he United States. J Am Soc Nephrol 13:1889-1893, 2002
44. Ahuja TS, Borucki M, Grady J: Highly active antiretroviral therapy improves survival of HIV-infected patients on dialysis. Am J Kidney Dis 36:574-580, 2000
45. Campbell J, Markowitz N, Fisher EJ, Cruz C: Continuous ambulatory peritoneal dialysis for the AIDS patient. In: Avram MM, Giordano C (eds). Ambulatory Peritoneal Dialysis. New York: Plenum, 1990:266-269
46. Rubin J: Prevalence of HIV virus among patients undergoing continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 35:144-145, 1989
47. Dressler R, Peters AT, Lynn RI: Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 86:787-790, 1989
48. Graham MM, Bonini LA, Verdi MM: A multicenter study: clinical practices of HIV infected patients on CAPD/CCPD. Adv Perit Dial 6:88-91, 1990
49. Schloth T, Genabe I, Pilgrim W, Jorden A, Fein PA, Avram MM: Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Perit Dial 8:250-252, 1992
50. Wasser WG, Boyle MJ, Brandon S, Gruber SJ, Winston RV, Feldman NS: HIV positivity does not predispose peritoneal dialysis patients to peritonitis. J Am Soc Nephrol 2:369, 1991
51. Ramaswamy CR, Sreedhara R, Fein PA, Dedios A, Avam MM: Characteristics of peritonitis in HIV infected patients treated by peritoneal dialysis. J Am Soc Nephrol 8:270A-271A, 1997
52. Baumgartner DD, Arterbery VE, Hale AJ, Gupta RK, Bradley SF: Peritoneal dialysis-associated tuberculous peritonitis in an intravenous drug user with acquired immunodeficiency syndrome. Am J Kidney Dis 14:154-157, 1989
53. Elsey RM, Carson RW, Dubose TD Jr: Pasteurella multocida peritonitis in an HIV-positive patient on continuous cycling peritoneal dialysis. Am J Nephrol 11:61-63, 1991
54. Lewis M, Gorban-Brennan NL, Kliger A, Cooper K, Finkelstein FO: Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv Perit Dial 6:136-138, 1990
55. Perazella M, Elsen T, Brown E: Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 21:319-321, 1993
56. Parsonnet J: Trichosporon beigelii peritonitis. South Med J 82:1062-1063, 1989
57. Abitol C, Zilleruelo G, Strauss J, Montane B, Martin L: Dialysis treatment of pediatric patients infected with the human immunodeficiency virus. J Am Soc Nephrol 8:215A, 1997
58. Williams PF, Swan B, Cunningham K: Continuous ambulatory peritoneal dialysis fluid: another fluid positive for HIV antibody. Br Med J 293:885, 1986
59. Kupferman JC, Nuovo G, Kaskel RJ, Malan S, Watson AJ: Lack of recovery of human immunodeficiency virus in peritoneal dialysis fluid and in urine by polymerase chain reaction in a child. Perit Dial Int 10:67-70, 1990
60. Correa-Rotter R, Saldivar S, Soto LE, de Leon PS, Pena JC: Recovery of HIV antigen in peritoneal dialysis fluid. Perit Dial Int 10:67-70, 1990
61. Breyer JA, Harbison MA: Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 21:23-25, 1993
62. Scheel PJ, Farzadegan H, Ford D, Malan S, Watson AJ: Recovery of human immunodeficiency virus from in peritoneal dialysis effluent. J Am Soc Nephrol 5:1926-1929, 1995
63. Farzadegan H, Ford D, Malan M, Masters B, Scheel Jr PJ: HIV-1 survival kinetics in peritoneal dialysis effluent. Kidney Int 50:1659-1662, 1996
64. Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. Available at http://www.hivatis.org, accessed
65. Nannery WM, Stoldt HS, Fares LG II: Hemodialysis access performed on patients with human immunodeficiency virus. Surg Gynecol Obstet 173:387-390, 1991
66. Brock JS, Sussman M, Wamsley M, Mintzer R, Baumann FG, Riles TS: The influence of human immunodeficiency virus infection and intravenous drug abuse on complications of hemodialysis access surgery. J Vasc Surg 16:904-912, 1993
67. Ifudu O, Matthew JJ, Mayers JD, Macey LJ, Brezsnyak W, Reydel C, McClendon E, Surgue T, Rao TKS, Friedman EA: Severity of AIDS and the response to EPO in uremia. Am J Kidney Dis 30:28-35, 1997
68. Schoenfeld PY, Feduska NJ: Acquired immunodeficiency syndrome and renal disease: report from the National Kidney Foundation-National Institutes of Health Task Force on AIDS and Kidney Disease. Am J Kidney Dis 16:14-25, 1990
69. Wittwer CT, Smith AM, Ash KO,DeWitt CW: False positive antibody tests for human immunodeficiency virus in transplant patients with antilymphocyte antibodies. Transplantation 44:843-844, 1987
70. Jindal R, Solomon M, Burrows L: False positive tests for HIV in a woman with lupus and renal failure. N Engl J Med 328:1281-1282, 1993
71. Agbalika F, Ferchal F, Garnier JP, Eugene M, Bedrossian J, Lagrange PH: False positive HIV antigens related to emergence of a 25-30kd protein in organ recipients. AIDS 6:959-962, 1992
72. Vincent F, Belec L, Glotz D, Nenoyo-Calonge V, Dubuost A, Bariety J: False positive neutralizable HIV antigens detected in organ transplant recipients. AIDS 7:741-742, 1993
73. Simonds RJ: HIV transmission by organ and tissue transplantation. AIDS 7(suppl 2):S35-S38, 1993
74. Bowen II PA, Lobel SA, Caruana RJ, Leffell MS, House MA, Rissing PJ, Humphries AL: Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med 108:46-48, 1988
75. Ward JW, Holmberg SD, Allen JR, Leffell MS, House MA, Rissing PJ, Humphries AL: Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med 318:473-478, 1988
76. Quarto M, Germanario C, Fontana A, Barbuti S: HIV transmission through kidney transplantation from a living related donor. N Engl J Med 320:1754, 1989
77. Simonds RJ, Holmberg SD, Hurwitz RI, Coleman TR, Bottenfield S, Conley MT, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, Rayfield MA, Rogers MF: Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N Engl J Med 326:959-962, 1992
78. Hooi LS: Human immunodeficiency virus infection in recipients of living unrelated donor renal transplants - a report of four cases. Med J Malaysia 48:232-235, 1993
79. Barri YM, Ellis ME, Al-Furayh O, Qunibi W, Taher S, Al-Sabban E, Bernvil S: Renal transplantation associated with HIV infection: a Saudi Arabian experience and review of literature. Clin Transplant 5:233-240, 1991
80. Ounibi W: High HIV and HbsAg infection rate in recipients of commercial transplants. J Am Soc Nephrol 4:957, 1993
81. Dummer JS, Erb S, Breinig MK, Ho M, Rinaldo Jr. CR, Gupta P, Ragni M, Tzakis AG, Makowa L, Thiel DV, Starzl TE: Infection with human immunodeficiency virus in the Pittsburgh transplant population. Transplantation 47:134-140, 1989
82. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour Jr HH: Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis 13:537-547, 1991
83. Delaney V, Sumrani N, Hong J, Davis R, Sommer B: HIV disease in renal allograft recipients. J Am Soc Nephrol 1:756, 1990
84. Schelling JR, Baum KF, Teitelbaum I: Didanosine administration in a human immunodeficiency virus positive renal transplant patient. Am J Kidney Dis 22:60-63, 1993
85. Spital A: Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of US transplant centers. Transplantation 65:1187-1191, 1998
86. Stock P, Roland M, Carlson L, Freise C, Hirose R, Terrault N, Frassetto L, Coates T, Roberts J, Ascher N: Solid organ transplantation in HIV-positive patients. Transplant Proc 33:3646-3648, 1999
87. Ippolito G, Puro V, DeCarli G: The risk of occupational human immunodeficiency virus infection in health-care workers. Italian multicenter study. The Italian Study Group on Occupational Risk of HIV Infection. Arch Intern Med 153:1451-1458, 1993
88. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mortal Wkly Rep 44:929-933, 1995
89. Gerberding JL: Prophylaxis for occupational exposures to HIV. Ann Intern Med 125:497-501, 1996
90. Cardo D, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM: A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 237:1485-1490, 1997
91. Update: provisional public health service recommendations for chemoprophylaxis after occupational exposures to HIV. MMWR Morb Mortal Wkly Rep 45:468-480, 1996
92. Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 36:107-118, 1990
93. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 37:377-387, 1988
94. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep 40(RR-8):1-8, 1991
95. Vijayvargiya R, Bosch JP: Dialysis and transplantation in patients with HIV infection. In: Kimmel PL, Berns JS (eds). Renal and Urologic Aspects of HIV infection. New York: Churchill Livingstone, 1995:253-277
96. Scheel PJJ, Malan M: Disposal of dialysate in HIV-positive patients: an update. Adv Ren Replace Ther 3:298-301, 1996
97. Perez GO, Ortiz C, De Medina M, Schiff E, Bourgoignie JJ: Lack of transmission of human immunodeficiency virus in chronic hemodialysis patients. Am J Nephrol 8:123-126, 1988
98. Berlyne G, Kaczmarek RG, Hamburger S, Hamilton P, Moore Jr. RM, Charney AN, Kahn T, Gruber M, Kaufman CE, Goffinet J, Bernard MA: Seroprevalence of antibodies to the human immunodeficiency virus in dialysis workers: results of a multi-center study. Nephron 62:44-443, 1992
99. Velandria M, Fridkin SK, Cardenas V, Boshell J, Ramirez G, Bland L, Iglesias A: Transmission of HIV in dialysis center. Lancet 345:1417-1422, 1995
100. Dyer E: Argentinian doctors accused of spreading AIDS. Br Med J 307:584, 1993
101. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation. Am J Kidney Dis 30:859-871, 1997
102. Shrivastava D, Rao TKS, Sinert R, Khurana E, Lundin AP, Friedman EA: The efficacy of erythropoietin in HIV infected end stage renal disease patients treated by maintenance hemodialysis. Am J Kidney Dis 25:721-725, 1995
103. Berns JS, Cohen RM, Rudnick MR, Bennett WM: Renal aspects of antimicrobial therapy for HIV infection. In: Kimmel PL, Berns JS (eds). Renal and Urologic Aspects of HIV Infection. New York: Churchill Livingstone, 1995:195-235